top of page

Our Highlights

Stay up to date with the latest news

October 2026.
VaxSynergy at ISV 2026!

VaxSynergy was represented at the International Society for Vaccines (ISV) 2026 Congress, where our team presented a scientific poster highlighting our research.

March 2026.
Our first poster presentation!

Our team, represented by Marilène and Martina, participated in the Scientific Day of the Axe Maladies Infectieuses et Immunitaires at the CRCHUQ–Université Laval.​

April 2026.
Another publication!

Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants

December 2025.
Our first publication!

PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines.​

October 2025.
"Groundbreaking discoveries"

VaxSynergy is made possible through the support of Médicament Québec and the collaboration of our industrial and strategic partners.​​

bottom of page